AxoGen, Inc. (NASDAQ:AXGN – Free Report) – Investment analysts at HC Wainwright issued their Q3 2025 earnings per share (EPS) estimates for AxoGen in a research note issued to investors on Tuesday, September 30th. HC Wainwright analyst Y. Chen forecasts that the medical equipment provider will post earnings per share of ($0.01) for the quarter. HC Wainwright currently has a “Buy” rating and a $25.00 price objective on the stock. HC Wainwright also issued estimates for AxoGen’s Q4 2025 earnings at ($0.01) EPS, FY2025 earnings at ($0.09) EPS, Q1 2026 earnings at $0.00 EPS, Q2 2026 earnings at $0.02 EPS, Q3 2026 earnings at $0.05 EPS, Q4 2026 earnings at $0.07 EPS and FY2026 earnings at $0.14 EPS. AxoGen Price PerformanceShares of AxoGen stock opened at $17.88 on Friday.